Analyst Information for Inovio Pharmaceuticals Inc.

$ 20.96   -0.49 (-2.28%) Volume: 38.41m 3:44 PM EDT Jul 6, 2020
Consensus Rating Average
Consensus Rating for INO is HOLD
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
Strong Buy 1.0 - 1.5
Moderate Buy 1.6 - 2.5
Hold 2.6 - 3.5
Moderate Sell 3.6 - 4.5
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 2.75
Previous Average Recommendation 1.75
Change in Average Recommendation 1.00
Number of Analysts Reporting 8
Strong Buy
1.0
Current: 2.75
Previous: 1.75
Change: 1.00
Strong Sell
5.0
Consensus Rating Industry Comparison
Industry: MED-BIOMED/GENE
Number of companies in industry with recommendations 394
Rank Recommendation relative to companies in its industry 320
Ranked 320 in Industry
1394 MED-BIOMED/GENE
Analyst Recommendations
Analysts recommending Strong Buy 2
Analysts recommending Moderate Buy 0
Analysts recommending Hold 5
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 1
Vertical Bar Chart
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 5 4 5
Moderate Buy 0 0 0 0
Hold 5 3 3 2
Moderate Sell 0 0 0 0
Strong Sell 1 0 0 0
Mean Rec. 2.75 1.75 1.86 1.57

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.    RT = Real-Time,  EOD = End Of Day,  PD = Previous Day.   Market Data powered by QuoteMedia. Analyst ratings by Zacks.   Terms of Use.